These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension. Hira HS; Kumar J; Tyagi SK; Jain SK Indian J Chest Dis Allied Sci; 2003; 45(3):165-71. PubMed ID: 12866633 [TBL] [Abstract][Full Text] [Related]
25. Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis. Ferreira Rde C; Domingues AL; Markman Filho B; Veras FH; Batista LJ; Albuquerque Filho ES Acta Trop; 2009 Aug; 111(2):119-24. PubMed ID: 19524079 [TBL] [Abstract][Full Text] [Related]
26. [Gaseous disorders and their role in the development of hepatopulmonary syndrome in liver cirrhosis associated with COPD]. Nevzorova VA; Pestrikova TL; Kochetkova EA; Mokshina MV; Osvald M; Dutrele S; Massard Zh Eksp Klin Gastroenterol; 2013; (6):11-4. PubMed ID: 24772853 [TBL] [Abstract][Full Text] [Related]
28. Detection of hepatopulmonary syndrome in patients with liver cirrhosis using 3D contrast echocardiography. Gaber R; Ziada DH; Kotb NA; Abo El-Magd GH; Hamisa M Arab J Gastroenterol; 2012 Mar; 13(1):14-9. PubMed ID: 22560819 [TBL] [Abstract][Full Text] [Related]
29. [Hepato-pulmonary syndrome]. Bozomitu L; Moraru E; Stana B; Burlea M; Aprodu G; Moraru D Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):625-32. PubMed ID: 21243785 [TBL] [Abstract][Full Text] [Related]
30. Influence of an upright body position on the size of intrapulmonary blood shunts in patients with advanced liver cirrhosis. Boryczka G; Hartleb M; Rudzki K; Janik MA J Physiol Pharmacol; 2015 Dec; 66(6):855-61. PubMed ID: 26769835 [TBL] [Abstract][Full Text] [Related]
31. Hepatopulmonory syndrome--an uncommon and severe complication of certain liver diseases. Sarkar P; Basu AK; Mandal SK; Basu D; Banerjee R; Pal SK; Bandopadhyay D; Chakraborty N J Indian Med Assoc; 2005 Sep; 103(9):469-70, 472. PubMed ID: 16493866 [TBL] [Abstract][Full Text] [Related]
32. Raised plasma levels of H Bera C; Thangaraj K; Pati PK; Ramachandran J; Balasubramanian KA; Ramachandran A; Zachariah U; Sajith KG; Goel A; Eapen CE Indian J Gastroenterol; 2018 May; 37(3):209-214. PubMed ID: 29984390 [TBL] [Abstract][Full Text] [Related]
33. Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients. Enache I; Oswald-Mammosser M; Woehl-Jaegle ML; Habersetzer F; Di Marco P; Charloux A; Doutreleau S Respir Med; 2013 Jul; 107(7):1030-6. PubMed ID: 23615223 [TBL] [Abstract][Full Text] [Related]
34. Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome. Ames PR; Guardascione M; Batuca JR; Arcaro A; Gentile F; Amitrano L Scand J Gastroenterol; 2016 Jan; 51(1):73-7. PubMed ID: 26051624 [TBL] [Abstract][Full Text] [Related]
35. CHARACTER AND FREQUENCY OF THE VARIATIONS OF CO- AND POLYMORBID SYNTROPIC EXTRAHEPATIC LESIONS AND THEIR DEPENDENCE ON THE HEPATOPULMONARY SYNDROME SEVERITY DEGREE IN CIRRHOTIC PATIENTS. Abrahamovych O; Abrahamovych M; Tolopko S; Fayura O; Ferko M Georgian Med News; 2016 Nov; (Issue):34-41. PubMed ID: 28009313 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation. Saad NE; Lee DE; Waldman DL; Saad WE J Vasc Interv Radiol; 2007 Dec; 18(12):1576-80. PubMed ID: 18057294 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatopulmonary syndrome in children. Noli K; Solomon M; Golding F; Charron M; Ling SC Pediatrics; 2008 Mar; 121(3):e522-7. PubMed ID: 18310172 [TBL] [Abstract][Full Text] [Related]
38. Excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome: a single centre experience. Saigal S; Choudhary N; Saraf N; Kotecha H; Kakodkar R; Mohanka R; Rastogi A; Menon P; Goja S; Govil D; Vohra V; Soin A Clin Transplant; 2013; 27(4):530-4. PubMed ID: 23721501 [TBL] [Abstract][Full Text] [Related]
39. Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome. Pouriki S; Alexopoulou A; Chrysochoou C; Raftopoulos L; Papatheodoridis G; Stefanadis C; Pectasides D Liver Int; 2011 Oct; 31(9):1388-94. PubMed ID: 21771264 [TBL] [Abstract][Full Text] [Related]
40. Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension. Ma C; Crippin JS; Chapman WC; Korenblat K; Vachharajani N; Gunter KL; Brunt EM Liver Transpl; 2013 Jul; 19(7):741-50. PubMed ID: 23463612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]